Ixekizumab versus FAEs and methotrexate in treatment of nail psoriasis in patients with moderate-to-severe psoriasis

被引：1

作者：

Augustin, Matthias ^{[1
,9
]}

Mrowietz, Ulrich ^{[2
]}

Willsmann-Theis, Dagmar ^{[3
]}

Gerdes, Sascha ^{[2
]}

Fotiou, Konstantinos ^{[4
]}

Schuster, Christopher ^{[4
,5
]}

Mert, Can ^{[6
]}

Holzkaemper, Thorsten ^{[4
]}

Behrens, Frank ^{[7
]}

Pinter, Andreas ^{[8
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, German Ctr Hlth Serv Res Dermatol, Hamburg, Germany

[2] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Dept Dermatol, Campus Kiel, Kiel, Germany

[3] Univ Hosp Bonn, Clin & Polyclin Dermatol & Allergol, Bonn, Germany

[4] Eli Lilly & Co, Indianapolis, IN USA

[5] Med Univ Vienna, Dept Dermatol, Vienna, Austria

[6] HaaPACS GmbH, Schriesheim, Germany

[7] Goethe Univ Frankfurt, Ctr Innovat Diagnost & Therapy Rheumatol Immunol, Frankfurt, Germany

[8] Univ Hosp Frankfurt, Dept Dermatol Venereol & Allergol, Frankfurt, Germany

[9] Univ Med Ctr Hamburg Eppendorf, German Ctr Hlth Serv Res Dermatol, Martinistr 52, D-20246 Hamburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年

关键词：

EFFICACY;

D O I：

10.1111/ddg.15292

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：4

共 50 条

[41] NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF IXEKIZUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS
Hartz, S.
Walzer, S.
Dutronc, Y.
Kiri, Himatlal S.
Schacht, A.
Dakin, H.
VALUE IN HEALTH, 2016, 19 (07) : A576 - A576
[42] Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis
Feldman, Steven R.
Foster, Shonda A.
Zhu, Baojin
Burge, Russel
Al Sawah, Sarah
Goldblum, Orin M.
JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (12) : 1246 - 1252
[43] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
Egeberg, Alexander
Merola, Joseph F.
Schaekel, Knut
Puig, Luis
Mahar, Patrick D.
Wang, Isabella Yali
Pavo, Imre
Schuster, Christopher
Griffiths, Christopher E. M.
FRONTIERS IN MEDICINE, 2023, 9
[44] Comment on "Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis"
Lebwohl, Mark G.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E377 - E377
[45] Sustained Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis
Papp, Kim
Gottlieb, Alice B.
Shuler, Catherine L.
Burge, Russel T.
Cameron, Gregory
Kerr, Lisa
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[46] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis Reply
Gordon, Kenneth B.
Colombel, Jean-Frederic
Hardin, Dana S.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2102 - 2102
[47] The effects of age, gender, weight, age at onset, psoriasis severity, nail involvement, and presence of psoriatic arthritis at baseline on the efficacy of ixekizumab in patients with moderate-to-severe psoriasis
Praiser, David
Heffernan, Michael
Dennehy, Ellen
See, Kyoungah
Goldblum, Orin
Paul, Carle
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB252 - AB252
[48] Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Boni E. Elewski
Andrew Blauvelt
Gaia Gallo
Eric Wolf
Missy McKean-Matthews
Russel Burge
Joseph F. Merola
Alice B. Gottlieb
Lyn C. Guenther
Dermatology and Therapy, 2022, 12 : 911 - 920
[49] Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Elewski, Boni E.
Blauvelt, Andrew
Gallo, Gaia
Wolf, Eric
McKean-Matthews, Missy
Burge, Russel
Merola, Joseph F.
Gottlieb, Alice B.
Guenther, Lyn C.
DERMATOLOGY AND THERAPY, 2022, 12 (04) : 911 - 920
[50] The use of methotrexate in treatment of moderate to severe psoriasis
Leung, W. Y.
Lau, K. H.
HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2009, 17 (01): : 13 - 19

← 1 2 3 4 5 →